Vivian E. Strong

Memorial Sloan Kettering Cancer Center — United States

Medicine · Health Sciences

55h-index15.4kcitations392works3.62yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Gastric Cancer Management and Outcomes(213), Gastrointestinal Tumor Research and Treatment(79), Esophageal Cancer Research and Treatment(67), Metastasis and carcinoma case studies(65), Helicobacter pylori-related gastroenterology studies(38)

Publications323 total

Genomic and clinical parallels between US and Japanese gastric cancers: a propensity score-matched cohort study
British journal of surgery·2025Open Access
Data from ctDNA as a Molecular Biomarker in the Phase II Trial of Imatinib plus Binimetinib in Patients with Advanced Gastrointestinal Stromal Tumor
2025Open Access
Supplementary Data1 from ctDNA as a Molecular Biomarker in the Phase II Trial of Imatinib plus Binimetinib in Patients with Advanced Gastrointestinal Stromal Tumor
2025Open Access
Transpacific multicenter collaborative study of minimally invasive proximal gastrectomy vs. minimally invasive total gastrectomy for proximal gastric and gastroesophageal junction cancers: 3-month follow-up results
Surgical Endoscopy·2025
Hereditary diffuse gastric cancer spectrum associated with germline <i>CTNNA1</i> loss of function revealed by clinical and molecular data from 351 carrier families and over 37 000 non-carrier controls
Gut·2025· 3 citedOpen Access
A Novel Predictive Model for Cancer-Specific Surgical Risk Stratification of Patients Undergoing High-Risk Upper Gastrointestinal Oncologic Resections
Annals of Surgery·2025
Liquid Biopsy in Gastric Cancer—Can miRNA Decode a Heterogenous Disease?
JAMA Surgery·2025
ctDNA as a Molecular Biomarker in the Phase II Trial of Imatinib plus Binimetinib in Patients with Advanced Gastrointestinal Stromal Tumor
Clinical Cancer Research·2025
Genomic Signatures of Gastric Adenocarcinoma By Tumor Location-Modified Laurén Classification
The American Journal of Surgical Pathology·2025
Supplementary Tables1 from Clinical Implications of The Cancer Genome Atlas Molecular Classification System in Esophagogastric Cancer
2025Open Access
Figure S2 from Clinical Implications of The Cancer Genome Atlas Molecular Classification System in Esophagogastric Cancer
2025Open Access
Figure S3 from Clinical Implications of The Cancer Genome Atlas Molecular Classification System in Esophagogastric Cancer
2025Open Access
Supplementary Methods1 from Clinical Implications of The Cancer Genome Atlas Molecular Classification System in Esophagogastric Cancer
2025Open Access
Figure S1 from Clinical Implications of The Cancer Genome Atlas Molecular Classification System in Esophagogastric Cancer
2025Open Access
Abstract CT003: Non operative management of mismatch repair deficient tumors
Cancer Research·2025
Correction: D2 Lymphadenectomy for Gastric Cancer: Advancements and Technical Considerations
Annals of Surgical Oncology·2025Open Access
Figure S2 from Clinical Implications of The Cancer Genome Atlas Molecular Classification System in Esophagogastric Cancer
2025Open Access
Figure S1 from Clinical Implications of The Cancer Genome Atlas Molecular Classification System in Esophagogastric Cancer
2025Open Access
Data from Clinical Implications of The Cancer Genome Atlas Molecular Classification System in Esophagogastric Cancer
2025Open Access
Supplementary Methods1 from Clinical Implications of The Cancer Genome Atlas Molecular Classification System in Esophagogastric Cancer
2025Open Access
page 1 of 17Next →

Frequent Co-authors

Daniel G. Coit(25), Murray F. Brennan(22), Mithat Gönen(16), David H. Ilson(13), Jaffer A. Ajani(10), Thomas A. D’Amico(10), Hans Gerdes(10), Lawrence Kleinberg(10), Prajnan Das(9), Wayne L. Hofstetter(9), Mary F. Mulcahy(9), Christopher G. Willett(9), Rajesh N. Keswani(8), David J. Bentrem(8), Nicole R. McMillian(7), Laura H. Tang(7), Crystal S. Denlinger(6), James A. Hayman(6), Cameron D. Wright(6), Charles S. Fuchs(6)